With telehealth surging around the globe due to the COVID-19 pandemic, the UK National Health Services has released guidance that provides a set of good practice principles for third-party partners to follow....more
2/5/2021
/ Coronavirus/COVID-19 ,
Data Protection ,
Electronic Protected Health Information (ePHI) ,
General Data Protection Regulation (GDPR) ,
Health Care Providers ,
Infectious Diseases ,
Life Sciences ,
Patient Access ,
Personal Data ,
Regulatory Agenda ,
Telehealth ,
Telemedicine ,
UK
With the recent ruling that the Safe Harbor programme is invalid under European law, life sciences companies will need to review their strategies when exporting patient data to the United States....more
10/12/2015
/ Binding Corporate Rules ,
Data Privacy ,
Data Protection Authority ,
Data Security ,
EU ,
EU Data Protection Laws ,
European Commission ,
European Court of Justice (ECJ) ,
Health Information Technologies ,
Informed Consent ,
International Data Transfers ,
Life Sciences ,
Medical Devices ,
Personal Data ,
Pharmaceutical Industry ,
PHI ,
Prior Express Consent ,
SCC ,
Schrems I & Schrems II ,
Third-Party ,
Umbrella Agreement ,
US-EU Safe Harbor Framework